Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
9,12 USD | -0,22% | -2,36% | -18,86% |
Attività
Numero di dipendenti: 99
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Human Therapeutics
100,0
%
| 51 | 100,0 % | 57 | 100,0 % | +11,84% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
99,6
%
| 51 | 99,6 % | 57 | 99,6 % | +11,89% |
Europe
0,4
%
| 0 | 0,4 % | 0 | 0,4 % | +0,45% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Rick Winningham
CEO | Chief Executive Officer | 64 | 01/07/13 |
Aziz Sawaf
DFI | Director of Finance/CFO | 42 | 01/06/14 |
Stuart Knight
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/14 |
Richard Graham
CTO | Chief Tech/Sci/R&D Officer | - | - |
Rhonda Farnum
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/07/18 |
Aine Miller
PRN | Corporate Officer/Principal | 47 | - |
Stacy Pryce
PRN | Corporate Officer/Principal | - | - |
Brett Grimaud
LAW | General Counsel | 50 | 01/10/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Dean Mitchell
BRD | Director/Board Member | 68 | 01/06/14 |
Eran Broshy
BRD | Director/Board Member | 65 | 02/06/14 |
Burt Malkiel
BRD | Director/Board Member | 90 | 01/10/13 |
Director/Board Member | 59 | 01/07/20 | |
Susannah Gray
BRD | Director/Board Member | 63 | 26/02/23 |
Rick Winningham
CEO | Chief Executive Officer | 64 | 01/07/13 |
Jim Kelly
BRD | Director/Board Member | 43 | 11/04/23 |
Donal O'Connor
BRD | Director/Board Member | 73 | 21/10/15 |
Laurie Alsup
BRD | Director/Board Member | 70 | 13/02/18 |
Jeremy Grant
BRD | Director/Board Member | 36 | 21/12 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 48 559 955 | 41 512 139 ( 85,49 %) | 0 | 85,49 % |
Coordinate società
Theravance Biopharma, Inc.
901 Gateway Boulevard
94080, South San
+650 808 6000
http://www.theravance.comSettore
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-18,86% | 443 Mln | |
+25,83% | 661 Mrd | |
+27,00% | 566 Mrd | |
-6,76% | 352 Mrd | |
+20,34% | 332 Mrd | |
+3,00% | 283 Mrd | |
+13,09% | 231 Mrd | |
+5,46% | 200 Mrd | |
-9,61% | 195 Mrd | |
-6,26% | 145 Mrd |
- Borsa valori
- Azioni
- Azione TBPH
- Società Theravance Biopharma, Inc.